Polymorphisms in CYP-7A1, not APOE, influence the change in plasma lipids in response to population dietary change in an 8 year follow-up;: results from the Czech MONICA study

被引:37
作者
Hubacek, JA [1 ]
Pitha, J
Skodová, Z
Poledne, R
Lánská, V
Waterworth, DM
Humphries, SE
Talmud, PJ
机构
[1] Inst Clin & Expt Med, Lab Atherosclerosis Res, Prague, Czech Republic
[2] Univ Coll & Middlesex Sch Med, Dept Med, Rayne Inst, London, England
[3] Ctr Expt Cardiovasc Res, Prague, Czech Republic
关键词
cholesterol 7-alpha hydroxylase; apolipoprotein E; lipids; polymorphism; diet;
D O I
10.1016/S0009-9120(03)00025-0
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To evaluate the influence of variation in the genes for apolipoprotein E (APOE; epsilon2, epsilon3, epsilon4) and cholesterol-7alpha hydroxylase (CYP-7A1; -204A-->C) on plasma lipid level changes. Design and methods: 131 males for whom dietary composition markedly changed and total cholesterol decreased (from 6.21 +/- 1.31 mmol/L in 1988 - 5.43 +/- 1.06 mmol/L in 1996). over an 8 yr follow-up study. Polymorphisms were investigated using PCR. Results: APOE genotype influenced plasma total and LDL cholesterol, with carriers of the epsilon4 having the highest and epsilon2 carriers the lowest levels, this reached borderline significance for cholesterol in 1988 (p = 0.06) and strongly affected the 1996 levels of LDL cholesterol (p = 0.008). However, APOE did not influence the change in these measures over time. In contrast, the CYP-7A1 -204A-->C polymorphism did not affect lipid measures per se but was strongly associated with a dec tease in plasma total cholesterol [AA -0.38 (+/- 0.20) mmol/L, AC -0.65 +/- (0.08), CC -1.33 (+/- 0.3) mmol/L, p = 0.01] over the 8 yr time period. Conclusions: Variation in the CYP-7A1 gene may play an important role in an individual's sensitivity to dietary composition. (C) 2003 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:263 / 267
页数:5
相关论文
共 23 条
  • [1] Couture P, 1999, J LIPID RES, V40, P1883
  • [2] DALONGEVILLE J, 1994, APOLIPOPROTHISM ATHE, P289
  • [3] APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS
    DAVIGNON, J
    GREGG, RE
    SING, CF
    [J]. ARTERIOSCLEROSIS, 1988, 8 (01): : 1 - 21
  • [4] ELECTROPHORESIS FOR GENOTYPING - MICROTITER ARRAY DIAGONAL GEL-ELECTROPHORESIS ON HORIZONTAL POLYACRYLAMIDE GELS, HYDROLINK, OR AGAROSE
    DAY, INM
    HUMPHRIES, SE
    [J]. ANALYTICAL BIOCHEMISTRY, 1994, 222 (02) : 389 - 395
  • [5] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [6] HIXSON JE, 1990, J LIPID RES, V31, P545
  • [7] Hubácek JA, 2001, PHYSIOL RES, V50, P345
  • [8] Genetic determination of plasma lipids and insulin in the Czech population
    Hubacek, JA
    Waterworth, DM
    Poledne, R
    Pitha, J
    Skodová, Z
    Humphries, SE
    Talmud, PJ
    [J]. CLINICAL BIOCHEMISTRY, 2001, 34 (02) : 113 - 118
  • [9] Hubácek JA, 2000, PHYSIOL RES, V49, P307
  • [10] Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study
    Humphries, SE
    Talmud, PJ
    Hawe, E
    Bolla, M
    Day, INM
    Miller, GJ
    [J]. LANCET, 2001, 358 (9276) : 115 - 119